Serum ghrelin levels in patients with Behcet's disease
dc.contributor.author | Erden, Ilker | |
dc.contributor.author | Ucak, Haydar | |
dc.contributor.author | Demir, Betul | |
dc.contributor.author | Cicek, Demet | |
dc.contributor.author | Dertlioglu, Selma Bakar | |
dc.contributor.author | Aydin, Suleyman | |
dc.contributor.author | Ozturk, Savas | |
dc.date.accessioned | 2024-04-24T17:24:51Z | |
dc.date.available | 2024-04-24T17:24:51Z | |
dc.date.issued | 2016 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Introduction: Behcet's disease (BD) is a chronic, relapsing, systemic vasculitis of unknown etiology. Aim: To measure serum ghrelin levels in BD patients and healthy controls and to investigate its association with metabolic syndrome (MetS). Material and methods: Thirty BD patients and 30 healthy individuals were enrolled in the study. Ghrelin levels were measured in blood samples using ELISA. Results: The mean serum ghrelin level in BD patients (28.57 +/- 14.04) was significantly lower compared to healthy controls (40.72 +/- 23.21) (p = 0.01). The mean serum ghrelin level in BD patients who had MetS (24.18 +/- 12.73) was lower compared to BD patients who did not have MetS (30.77 +/- 14.45), but this difference was not significant (p > 0.05). Conclusions: Ghrelin levels were lower in BD patients compared to healthy controls. There was no association between reduced ghrelin levels and MetS; however, there was a negative correlation between ghrelin levels and disease activity. | en_US |
dc.identifier.doi | 10.5114/ada.2016.63884 | |
dc.identifier.endpage | 456 | en_US |
dc.identifier.issn | 1642-395X | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 28035223 | |
dc.identifier.scopus | 2-s2.0-85002179330 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 450 | en_US |
dc.identifier.uri | https://doi.org/10.5114/ada.2016.63884 | |
dc.identifier.uri | https://hdl.handle.net/11468/19858 | |
dc.identifier.volume | 33 | en_US |
dc.identifier.wos | WOS:000389786000009 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Termedia Publishing House Ltd | en_US |
dc.relation.ispartof | Postepy Dermatologii I Alergologii | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Behcet's Disease | en_US |
dc.subject | Ghrelin | en_US |
dc.subject | Metabolic Syndrome | en_US |
dc.subject | Insulin Resistance | en_US |
dc.title | Serum ghrelin levels in patients with Behcet's disease | en_US |
dc.title | Serum ghrelin levels in patients with Behcet's disease | |
dc.type | Article | en_US |